Tablets & Capsules


Issue link:

Contents of this Issue


Page 48 of 51

Tablets & Capsules May/June 2021 47 calendar Excipients: Compliance with Com- pendial and GMP Requirements. May 24-26. Online. Co-Sponsored by IPEC-Americas and CfPA (ipec, 571 814 3449). Natural Products Expo West. May 24-27. Online. Conducted by Informa (, 303 390 1776). Mary Frances Picciano Dietary Sup- plement Research Practicum. May 25-27. Online. Conducted by the NIH Office of Dietary Supplements (, ODSPrac Tooling Maintenance Series-Mea- sure. May 27. Online. Conducted by I Holland (, info@ Canadian Society of Pharmaceuti- cal Scientists/PSJ/CC-CRS Sympo- sium — Pharmaceutical Sciences in a Pandemic World. May 31-June 3. Online. Conducted by the Canadian Society for Pharmaceutical Sciences (, 866 317 8461). June Pharmacovigilance and Drug Safety. June 7-8. Online. Conducted by Con- ferenceSeries (europharmacovigilance., 201 380 5561). Scientifically Sound Specifications – No "By-Inputs" Here. June 8. Online. Conducted by EAS Consulting Group (, 571 447 5500). Tablet Press Training Seminar Level 2 with Certificate. July 21-22 in Cypress, CA. Conducted by Natoli Engineering (, 636 926 8900). FY 2021 Generic Drug Science and Research Initiatives Public Workshop. June 23. Online. Conducted by the FDA ( human-drugs, 888 463 6332). Traditional Medicine, Therapies and Modern Health Care. June 23-24. Online. Conducted by Con- ferenceSeries (traditionalmedicine, 201 380 5561). Tooling Maintenance Series-Pol- ish. June 24. Online. Conducted by I Holland (, info@ DIA Global Annual Meeting. June 27-July 1. Online. Conducted by Drug Information Association (www.dia, 215 442 6100). July Solid Dose Manufacturing. July 20-22. Online. Conducted by Techceuticals (, 216 658 8038). Pharmaceutical Chemistry. July 26-27 in London, UK. Conducted by Confer- enceSeries (pharmaceuticalchemistry., 201 380 5561). Developing and Implementing a Supplier Qualification Program for Dietary Supplements. July 29. Online. Conducted by EAS Consulting Group (, 571 447 5500). Tooling Maintenance Series- Lubricate & Store. July 29. Conducted by I Hol- land (, info@ supplier news CapsCanada launches liquid-filled capsule manufacturing service DANIA BEACH, FL—CapsCan- ada has launched a liquid-filled hard capsule manufacturing service to support the entire manufacturing process, from formulation and devel- opment through full-scale production in North America. Production will be done at a dedicated Health Canada- approved facility in Canada that has a full analytical lab, licensing for controlled drugs and substances including narcotics, and a choice of blister or bottle packaging. The facil- ity is waiting for FDA approval for the manufacture and testing of solid oral dosage forms. ACG adds labs division in India SHIRWAL, India—ACG has added a lab for process development in Shirw- al, India. The AGG Laboratories facili- ty will provide customers and partners with a research, development, testing, and training environment dedicated to the collaborative exploration of all aspects of oral solid dosage manufac- turing. The new lab allows ACG clients to explore and solve their manufactur- ing needs and challenges in a dedicat- ed, state-of-the-art space. The facility also answers a growing customer need for training and assistance with clinical trials and development projects. Lonza expands solid form selection services BEND, OR—Lonza has expanded its solid form selection services at the company's Center of Excellence for bioavailability site in Bend, OR. The solid form services will enhance the company's SimpliFiH Solutions first-in- human services, intended to speed the advancement of small molecules, and allow the company to meet acceler- ated timelines for increasingly complex molecules. The company's comprehen- sive solid form services include form and salt/cocrystal screening, solid state characterization, chemical composi- tion, solubility and dissolution, and powder properties. Catalent partners with Cybin on antipsycotic ODT SOMERSET, NJ—Catalent has signed an agreement with Canadian biotech company Cybin to apply Catalent's Zydis orally disintegrating tablet (ODT) technology to deliver Cybin's novel deuterated tryptamine, a potential therapy for treatment- resistant psychiatric disorders. Zydis creates a freeze-dried tablet that rap- idly dissolves in the mouth without water, which would allow pre-gastric delivery of deuterated tryptamine and prevent first pass metabolism, improving the drug's pharmacoki- netic profile. The project commenced in April and will involve feasibility studies of ODT doses with varying quantities of deuterated tryptamine along with other excipients.

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TCMay/June21